63MO TG4001 therapeutic vaccination combined with PD-L1 blocker avelumab remodels the tumor microenvironement (TME) and drives antitumor responses in human papillomavirus (HPV)+ malignancies
Authors:
- 1 December 2020
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 31, S1442